(Q36899904)
Statements
1 reference
Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non small cell lung cancer (English)
1 reference
Pasi A Jänne
1 reference
Bruce E Johnson
1 reference
David Jackman
1 reference
1 August 2007
1 reference
1 reference
13
1 reference
15 Pt 2
1 reference
s4628-31
1 reference
Identifiers
1 reference
1 reference